Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease
UB-312 was immunogenic in patients with early Parkinson’s disease. UB-312 was generally safe and well-tolerated….
Social Media
Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)
Through a sponsorship agreement CCIC’s accredited Canadian Cannabis Syllabus will be made available to the…
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
J-A. Sahel (left)_B.Roska (right) J-A. Sahel (left)_B.Roska (right) Basel, Switzerland, June 22, 2023 –In recognition…
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
J-A. Sahel (left)_B.Roska (right) J-A. Sahel (left)_B.Roska (right) Basel, Switzerland, June 22, 2023 –In recognition…
Federal Area Median Income Limit Adjustment: More California Homeowners Eligible for COVID-19 Relief Grant of up to $80,000
Annual adjustment to income rates leads to increases in the 150% AMI rate for California…
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility…
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility…
Investors Grow Comfortably Numb to Market Volatility, Haven’t Reset Risk and Return Expectations, Finds Natixis Investment Managers Survey
Investors are still expecting double-digit investment returns – more than two times higher than what…
Amarin Announces Vascepa® (Icosapent Ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom of Saudi Arabia (KSA)
— VASCEPA® Approved in KSA To Reduce the Risk of Cardiovascular (CV) Events as an…
Monopar to Participate in the Radiopharma Forum by the Lake 2023
WILMETTE, Ill., June 21, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
Workato Launches AI@Work to Drive Business Efficiency at Scale with the Power of Generative AI
Enable businesses to adopt AI in their automations at scale to drive business efficiency Introducing…
Intuit Mailchimp Launches More Than 150 New and Updated Features
• Features include richer reporting and analytics, advanced segmentation, more e-commerce automations, and an improved…
Intuit Mailchimp Launches Over 150 New and Updated Features
Features include richer reporting and analytics, advanced segmentation, more e-commerce automations, SMS marketing, and an…
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor…
Sandoz introduces Act4Biosimilars Action Plan to accelerate patient access to biosimilar medicines
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in…
FOX News Digital Sees Year-Over-Year Increases While Leading News Brands With Multiplatform Views and Minutes
FOX News Marks 105 Consecutive Months as Most Engaged News Brand on Social Media NEW…
Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference
WILMETTE, Ill., June 14, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference
WILMETTE, Ill., June 14, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
Biogen Announces Changes to Its Board of Directors
Biogen Will Adjourn Its Annual Meeting of Stockholders Until June 26, 2023, to Give All…
Pyrra Technologies Closes Successful Seed Round
The markets may be down, but online threats are up. WASHINGTON–(BUSINESS WIRE)–Pyrra Technologies Inc. (“Pyrra”…